Clinical Trial Update: Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a potassium infusion to convert atrial fibrillation or atrial flutter has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Potassium infusion (potassium)

Snippet

Sponsor: Diakonhjemmet Hospital | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 4 | Status: COMPLETED